| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,181 |
18,222 |
$2.03M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,543 |
6,388 |
$467K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,586 |
8,466 |
$348K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,784 |
1,783 |
$260K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,134 |
8,029 |
$233K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,514 |
1,502 |
$128K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,731 |
5,671 |
$84K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
778 |
778 |
$74K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
512 |
507 |
$51K |
| 87081 |
|
4,117 |
4,076 |
$24K |
| 87634 |
|
244 |
244 |
$15K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
656 |
648 |
$14K |
| 99051 |
|
1,702 |
1,688 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,477 |
1,441 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
635 |
604 |
$8K |
| 87807 |
|
563 |
558 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
98 |
97 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
33 |
33 |
$2K |
| 86756 |
|
130 |
130 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
99 |
99 |
$855.36 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
36 |
36 |
$418.32 |
| 36415 |
Collection of venous blood by venipuncture |
102 |
98 |
$374.33 |
| 86308 |
|
43 |
43 |
$198.23 |
| 82565 |
|
38 |
37 |
$163.80 |
| 80051 |
|
25 |
24 |
$156.00 |
| 82550 |
|
25 |
24 |
$144.75 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13 |
13 |
$109.72 |
| 84520 |
|
26 |
25 |
$91.26 |
| 82947 |
|
25 |
24 |
$87.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
55 |
55 |
$53.02 |
| 81003 |
|
25 |
25 |
$50.00 |